Skip to main content

Table 2 Prevalent medications (ATC) upon admission and discharge after hip fracture surgery (n = 272)

From: Polypharmacy and adverse outcomes after hip fracture surgery

ATC-code medication Admission (n) Discharge (n) Difference (n)
A02B drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) 79 82 −3
B01AA vitamin K antagonists 13 12 −1
B01AB heparin group 1 90 +89
B01AC platelet aggregation inhibitors 108 89 −19
C01D vasodilators, (nitrates) 34 40 +6
C03 diuretics, all 113 66 −47
C03A low-ceiling diuretics (thiazides) 35 17 −18
C03C high ceiling diuretics (loop) 72 37 −35
C03D potassium-sparing agents (C03DA, aldosterone antagonists) 31 11 −20
C07A beta-blocking agents 85 84 −1
C08C-D calcium channel blockers 55 31 −24
C09A-C agents acting on the renin-angiotensin system 72 62 −10
C01-09 antihypertensives 179 148 −31
M05B drugs affecting bone structure and mineralization 68 83 +15
N02A opioids strong
(excl. tramadol)
14 45 +31
N02AX opioids weak (tramadol) 13 160 +147
N02B other analgesics (incl. paracetamol) 63 220 +157
N04B dopaminergic agents (antiparkinson) 15 15 +/−0
N05B anxiolytics (incl. benzodiazepines) 56 48 −8
N05C hypnotics and sedatives (incl. zolpidem and heminevrin) 80 78 −2
N06A antidepressants, totally 80 79 −1
N06AB SSRI only 66 63 −3
N06D psychoanaleptics (antidementia) 15 14 −1
R03A-B drugs for obstructive airway diseases 28 28 +/−0
S01E-X ophtalmologicals (eye drops) 31 31 +/−0